Literature DB >> 30485906

Untangling alpha synuclein fibrils by graphene quantum dots.

Daniel Ysselstein1, Dimitri Krainc1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30485906      PMCID： PMC6354238          DOI： 10.1002/mds.27511

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


× No keyword cloud information.
  4 in total

1.  Graphene quantum dots prevent α-synucleinopathy in Parkinson's disease.

Authors:  Donghoon Kim; Je Min Yoo; Heehong Hwang; Junghee Lee; Su Hyun Lee; Seung Pil Yun; Myung Jin Park; MinJun Lee; Seulah Choi; Sang Ho Kwon; Saebom Lee; Seung-Hwan Kwon; Sangjune Kim; Yong Joo Park; Misaki Kinoshita; Young-Ho Lee; Seokmin Shin; Seung R Paik; Sung Joong Lee; Seulki Lee; Byung Hee Hong; Han Seok Ko
Journal:  Nat Nanotechnol       Date:  2018-07-09       Impact factor: 39.213

Review 2.  α-Synuclein in Parkinson's disease.

Authors:  Leonidas Stefanis
Journal:  Cold Spring Harb Perspect Med       Date:  2012-02       Impact factor: 6.915

Review 3.  The many faces of α-synuclein: from structure and toxicity to therapeutic target.

Authors:  Hilal A Lashuel; Cassia R Overk; Abid Oueslati; Eliezer Masliah
Journal:  Nat Rev Neurosci       Date:  2013-01       Impact factor: 34.870

Review 4.  Therapeutic approaches to target alpha-synuclein pathology.

Authors:  Patrik Brundin; Kuldip D Dave; Jeffrey H Kordower
Journal:  Exp Neurol       Date:  2017-10-04       Impact factor: 5.330
  4 in total
  1 in total

1.  Graphene-Based Nanoparticles as Potential Treatment Options for Parkinson's Disease: A Molecular Dynamics Study.

Authors:  Ehsan Alimohammadi; Mohammad Khedri; Ahmad Miri Jahromi; Reza Maleki; Milad Rezaian
Journal:  Int J Nanomedicine       Date:  2020-09-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.